Cat: IPD-X41511

Recombinant Escherichia coli O157:H7 tadA Protein ,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    tadA

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Species

    Escherichia coli O157:H7

  • Source

    E. coli

  • Tag

    N- His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q8XA44

  • Expression Region

    1-167aa

  • Molecular Weight

    22.8 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

tadA, or tRNA adenosine deaminase, is an essential enzyme involved in the post-transcriptional modification of tRNA molecules, specifically catalyzing the hydrolytic deamination of adenosine to inosine at the wobble position of tRNA. This modification plays a critical role in enhancing codon recognition during protein synthesis, thereby influencing the efficiency and accuracy of translation. The research on tadA recombinant proteins has gained momentum due to its potential applications in biotechnology, including the development of novel therapeutic strategies and gene editing technologies like CRISPR-Cas9. Understanding the structure-function relationship of tadA can provide insights into its enzymatic mechanism and regulation. Furthermore, studying recombinant tadA proteins can facilitate improvements in the stability and activity of this enzyme for use in various applications, such as the engineering of tRNA for enhanced expression of proteins in heterologous systems. Advances in expression systems and purification techniques for tadA recombinants have opened new avenues for investigating its role in cellular metabolism, as well as its implications in diseases linked to tRNA modifications. Overall, the study of tadA and its recombinant forms is crucial for both fundamental biochemical research and practical applications in synthetic biology and medicine.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US